Savara Inc (SVRA NASDAQ) stock market data APIs
$6.4514
-0.53(-8.2%)
as of December 22, 2025
Try our APIs with
free plan!
Savara Inc Financial Data Overview
Price chart is built with
Anychart
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Prev. Close
6.4514
Open
5.9257
High
6.4786
Low
5.822
52 wk Range
1.89-7.005
Market Cap
1 231 M
Shares Outstanding
203 M
Revenue
1 000
EPS
-0.14
Beta
0.224
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Savara Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Savara Inc data using free add-ons & libraries
Get Savara Inc Fundamental Data
Savara Inc Fundamental data includes:
- Net Revenue: 1 000
- EBITDA: -120 388 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Savara Inc News
New
Savara resubmits MOLBREEVI BLA to FDA, seeks priority review
* Savara ( [https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fsavarapharma.com%2F&esheet=54382048&newsitemid=20251221214643&lan=en-US&anchor=Savara+Inc.&index=1&md5=f6d458de2e8896cb4...
3 High Growth Tech Stocks To Watch In The US Market
As the U.S. market grapples with fluctuating indices and AI bubble concerns, the Dow Jones Industrial Average recently hit an all-time high before retreating, while tech-heavy stocks like those in the...
Savara Inc. ticks higher amid takeover speculation
[Scientist looking through a microscope] sanjeri/E+ via Getty Images * Savara Inc. (SVRA [https://seekingalpha.com/symbol/SVRA]) pared a loss and ticked higher by 0.2% amid takeover speculation. ...
Savara (SVRA) Climbs 27.8% Ahead of 2 Health Conferences
We recently published 10 Small Caps With Big Double-Digit Gains. Savara Inc. (NASDAQ:SVRA) is one of the top performers of last week. Savara soared by 27.84 percent week-on-week, as investors positio...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
